Transcranial direct current stimulation (tDCS) didn't outperform a sham treatment in easing fatigue in adults with multiple sclerosis.| Multiple Sclerosis News Today
Certain immune cells in MS show abnormalities in activity and signs of reactions against the Epstein-Barr virus, a study says.| Multiple Sclerosis News Today
Living with a chronic illness such as multiple sclerosis (MS) can lead to mental health challenges, such as depression and anxiety.| Multiple Sclerosis News Today
Abata Therapeutics has chosen its first treatment candidate for development: the T-cell therapy ABA-101 for certain forms of progressive MS.| Multiple Sclerosis News Today
People with MS show similar changes in gut microbiome that are consistent across the U.S. and Asia, an analysis of studies showed.| Multiple Sclerosis News Today
Symptoms and early signs of MS vary from person to person. Common symptoms include movement problems, pain, fatigue, and vision problems.| Multiple Sclerosis News Today
In MS, the myelin sheath is damaged by the immune system's inflammatory attack. Learn more about its function and how it relates to MS.| Multiple Sclerosis News Today
MS is not usually fatal, but it may increase the risk of life-threatening complications. Learn more about MS progression and life expectancy.| Multiple Sclerosis News Today
MS is defined by the presence of lesions in the nervous system. Learn more about MS lesions and view a picture of what brain lesions look like on an MRI.| Multiple Sclerosis News Today
While diet cannot replace treatment, studies suggest that a balanced diet may help patients to better manage and control multiple sclerosis.| Multiple Sclerosis News Today
Iaso Bio has received clearance from the FDA to start clinical trials to test its CAR T-cell therapy equecabtagene autoleucel in MS patients.| Multiple Sclerosis News Today
MS is an autoimmune disease that affects the central nervous system. Learn more about MS types, causes, symptoms, diagnosis, and treatment.| Multiple Sclerosis News Today
